Bupropion Hydrochloride
- Product NDC
- 70518-1711
- 11-digit product format
- 705181711
- Labeler code
- 70518
- Product ID
- 70518-1711_b92ff49a-2b41-65b5-e053-2a95a90a0d7f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090693
- Marketing category
- ANDA
- Marketing start
- 2018-12-06
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1711-1 | 70518171101 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-1711-1) | 2019-01-28 | 0000-00-00 | No | No | Current |